{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:24:45Z","timestamp":1786987485318,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cryobiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cryobiol.2025.105214","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T23:31:17Z","timestamp":1740785477000},"page":"105214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Long term stability of preservative-free and lyophilized PRGF eye drops stored at different temperature conditions: in vitro comparative study"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8386-5303","authenticated-orcid":false,"given":"Eduardo","family":"Anitua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-1517","authenticated-orcid":false,"given":"Mar\u00eda de la","family":"Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4422-4527","authenticated-orcid":false,"given":"Mohammad Hamdan","family":"Alkhraisat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cryobiol.2025.105214_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109061","article-title":"Comparative study of the lipid profile of tears and plasma enriched in growth factors","volume":"219","author":"Acera","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.cryobiol.2025.105214_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jop.2023.0155","article-title":"Blood-derived eye drops for the treatment of corneal neuropathic pain","volume":"40","author":"Anam","year":"2024","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.cryobiol.2025.105214_bib14","article-title":"Use of allogeneic platelet-rich plasma for the treatment of autoimmune ocular surface disorders: case series","volume":"3","author":"Mancini","year":"2023","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"10.1016\/j.cryobiol.2025.105214_bib29","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s40123-023-00827-5","article-title":"Allogeneic serum eye drops: a randomized clinical trial to evaluate the clinical effectiveness of two drop sizes","volume":"12","author":"Vermeulen","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.cryobiol.2025.105214_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtos.2017.05.005","article-title":"TFOS DEWS II introduction","volume":"15","author":"Nelson","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.cryobiol.2025.105214_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.cryobiol.2025.105214_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239271","article-title":"Defining dry eye from a clinical perspective","volume":"21","author":"Tsubota","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cryobiol.2025.105214_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jtos.2023.04.006","article-title":"TFOS lifestyle: impact of societal challenges on the ocular surface","volume":"28","author":"Stapleton","year":"2023","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.cryobiol.2025.105214_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2230.2011.04303.x","article-title":"Antibacterial effect of plasma rich in growth factors (PRGF(R)-Endoret(R)) against Staphylococcus aureus and Staphylococcus epidermidis strains","volume":"37","author":"Anitua","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cryobiol.2025.105214_bib13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/medicina59050928","article-title":"Impact of plasma rich in growth factors (PRGF) eye drops on ocular redness and symptomatology in patients with dry eye disease","volume":"59","author":"Lozano-Sanroma","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.cryobiol.2025.105214_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000439280","article-title":"Autologous plasma rich in growth factors eyedrops in refractory cases of ocular surface disorders","volume":"55","author":"Merayo-Lloves","year":"2015","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.cryobiol.2025.105214_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/02713683.2023.2173237","article-title":"Beneficial effects of plasma rich in growth factors (PRGF) versus autologous serum and topical insulin in ocular surface cells","volume":"48","author":"Anitua","year":"2023","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.cryobiol.2025.105214_bib17","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1038\/s41598-022-12879-x","article-title":"Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease","volume":"12","author":"Metheetrairut","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cryobiol.2025.105214_bib30","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.3390\/jcm12093126","article-title":"The comparison between the composition of 100% autologous serum and 100% platelet-rich plasma eye drops and their impact on the treatment effectiveness of dry eye disease in primary sjogren syndrome","volume":"12","author":"Wr\u00f3bel-Dudzi\u0144ska","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cryobiol.2025.105214_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0000000000002519","article-title":"Short- and long-term stability of plasma rich in growth factors eye drops","author":"Anitua","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.cryobiol.2025.105214_bib7","article-title":"Stability of freeze-dried plasma rich in growth factors eye drops stored for 3 months at different temperature conditions","author":"Anitua","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.cryobiol.2025.105214_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1167\/tvst.9.7.35","article-title":"Development and optimization of freeze-dried eye drops derived from plasma rich in growth factors technology","volume":"9","author":"Anitua","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.cryobiol.2025.105214_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052434","article-title":"Artificial tears: biological role of their ingredients in the management of dry eye disease","volume":"23","author":"Labetoulle","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cryobiol.2025.105214_bib15","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.2147\/OPTH.S384819","article-title":"Personalized management of dry eye disease: beyond artificial tears","volume":"16","author":"Matossian","year":"2022","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.cryobiol.2025.105214_bib10","article-title":"Efficacy of plasma rich in growth factors (PRGF) in stage 1 neurotrophic keratitis","author":"Ghalibafan","year":"2023","journal-title":"Res Sq"},{"key":"10.1016\/j.cryobiol.2025.105214_bib19","first-page":"Cd009327","article-title":"Autologous serum eye drops for dry eye","volume":"2","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cryobiol.2025.105214_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/tvst.9.6.22","article-title":"Quantification of growth factors and fibronectin in diverse preparations of platelet-rich plasma for the treatment of ocular surface disorders (E-PRP)","volume":"9","author":"Rodriguez","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.cryobiol.2025.105214_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/vision5030034","article-title":"Use of plasma rich in growth factors and ReGeneraTing agent matrix for the treatment of corneal diseases","volume":"5","author":"Sanchez-Avila","year":"2021","journal-title":"Vision"},{"key":"10.1016\/j.cryobiol.2025.105214_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jtos.2022.04.007","article-title":"A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America","volume":"25","author":"Soifer","year":"2022","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.cryobiol.2025.105214_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810701","article-title":"Impact of freeze-drying on cord blood (CB), serum (S), and platelet-rich plasma (CB-PRP) preparations on growth factor content and in vitro cell wound healing","volume":"23","author":"Valente","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cryobiol.2025.105214_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-60787-z","article-title":"Storage conditions affect the composition of the lyophilized secretome of multipotent mesenchymal stromal cells","volume":"14","author":"Rogulska","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cryobiol.2025.105214_bib11","first-page":"199","article-title":"Pharmaceutical preformulation and formulation","volume":"199","author":"Gibson","year":"2001","journal-title":"Drugs Pharmaceut. Sci."},{"key":"10.1016\/j.cryobiol.2025.105214_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107813","article-title":"Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study","volume":"9","author":"Drago","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cryobiol.2025.105214_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jobcr.2019.06.013","article-title":"Antimicrobial effects of various platelet rich concentrates-vibes from in-vitro studies-a systematic review","volume":"9","author":"Varshney","year":"2019","journal-title":"J. Oral Biol. Craniofac. Res."}],"container-title":["Cryobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011224025000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011224025000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:25:20Z","timestamp":1762122320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011224025000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"alternative-id":["S0011224025000203"],"URL":"https:\/\/doi.org\/10.1016\/j.cryobiol.2025.105214","relation":{},"ISSN":["0011-2240"],"issn-type":[{"value":"0011-2240","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term stability of preservative-free and lyophilized PRGF eye drops stored at different temperature conditions: in vitro comparative study","name":"articletitle","label":"Article Title"},{"value":"Cryobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cryobiol.2025.105214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Cryobiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105214"}}